Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT)
Andreas Greinacher, Linda Schönborn, Florian Siegerist, et al.
Seminars in Hematology (2022) Vol. 59, Iss. 2, pp. 97-107
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

COVID-19, post-acute COVID-19 syndrome (PACS, “long COVID”) and post-COVID-19 vaccination syndrome (PCVS, “post-COVIDvac-syndrome”): Similarities and differences
Felix Scholkmann, Christian-Albrecht May
Pathology - Research and Practice (2023) Vol. 246, pp. 154497-154497
Open Access | Times Cited: 92
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 53
Vaccine-induced immune thrombotic thrombocytopenia
Douglas B. Cines, Andreas Greinacher
Blood (2023) Vol. 141, Iss. 14, pp. 1659-1665
Open Access | Times Cited: 47
Vaccine-induced immune thrombotic thrombocytopenia is mediated by a stereotyped clonotypic antibody
Jing Jing Wang, Bridie Armour, Tim Chataway, et al.
Blood (2022) Vol. 140, Iss. 15, pp. 1738-1742
Open Access | Times Cited: 41
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
Farokh Dotiwala, Arun Kumar Upadhyay
Vaccines (2023) Vol. 11, Iss. 10, pp. 1585-1585
Open Access | Times Cited: 32
Platelet factor 4 triggers thrombo‐inflammation by bridging innate and adaptive immunity
Andreas Greinacher, Theodore E. Warkentin
International Journal of Laboratory Hematology (2023) Vol. 45, Iss. S2, pp. 11-22
Open Access | Times Cited: 25
SARS-CoV-2 Vaccination and Neuroimmunological Disease
Alice Willison, Marc Pawlitzki, Michael P. Lunn, et al.
JAMA Neurology (2024) Vol. 81, Iss. 2, pp. 179-179
Closed Access | Times Cited: 10
Thrombosis with thrombocytopenia syndrome (TTS) and vaccine-induced immune thrombocytopenia and thrombosis (VITT): Brighton Collaboration case definitions and guidelines for data collection, analysis, and presentation of immunisation safety data
Linda Schönborn, Sue Pavord, Vivien Chen, et al.
Vaccine (2024) Vol. 42, Iss. 7, pp. 1799-1811
Open Access | Times Cited: 9
Incidence and management of the main serious adverse events reported after COVID‐19 vaccination
Teresa Padilla‐Flores, Alicia Sampieri, Luis Vaca
Pharmacology Research & Perspectives (2024) Vol. 12, Iss. 3
Open Access | Times Cited: 9
Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
А. D. Makatsariya, S. V. Akinshina, А. V. Vorobev, et al.
Obstetrics Gynecology and Reproduction (2025) Vol. 19, Iss. 1, pp. 97-109
Open Access | Times Cited: 1
Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders
Yi Zhang, Anna-Lise Bissola, Jared Treverton, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 4, pp. 1012-1012
Open Access | Times Cited: 7
Safety of COVID-19 Vaccines: Spotlight on Neurological Complications
Giacomo Tondo, Eleonora Virgilio, Andrea Naldi, et al.
Life (2022) Vol. 12, Iss. 9, pp. 1338-1338
Open Access | Times Cited: 23
Potential mechanisms of vaccine-induced thrombosis
Marco Marietta, Valeria Coluccio, Mario Luppi
European Journal of Internal Medicine (2022) Vol. 105, pp. 1-7
Open Access | Times Cited: 21
Assessing vaccine safety during a pandemic: Recent experience and lessons learned for the future
Steven Black, Rebecca E. Chandler, Kathryn M. Edwards, et al.
Vaccine (2023) Vol. 41, Iss. 25, pp. 3790-3795
Open Access | Times Cited: 13
Case Report: Anti-platelet factor 4 -mediated immunothrombosis in a patient with ANCA vasculitis – a shared mechanism of NETosis
Lital Remez-Gabay, Olga Olgav Vdovich, Luiza Akria, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Intranasal administration of adenoviral vaccines expressing SARS-CoV-2 spike protein improves vaccine immunity in mouse models
Tobias Freitag, Riku Fagerlund, Nihay Laham-Karam, et al.
Vaccine (2023) Vol. 41, Iss. 20, pp. 3233-3246
Open Access | Times Cited: 10
Immunothrombotic involvement in COVID-19
José A. Páramo, María Marcos‐Jubilar
Elsevier eBooks (2025), pp. 335-352
Closed Access
Lipid signatures of immunothrombosis: insights from VITT
Tamam Bakchoul, Madhumita Chatterjee
Research and Practice in Thrombosis and Haemostasis (2025) Vol. 9, Iss. 2, pp. 102725-102725
Open Access
Thromboembolic Events in the Era of COVID‐19: A Detailed Narrative Review
Manal Mansour, Christophe El Rassi, Bshara Sleem, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2025) Vol. 2025, Iss. 1
Open Access
Vaccination and Platelet Biology: Unraveling the Immuno-Hemostatic Interplay
Sneha Ratnapriya, Shivraj M. Yabaji
Vaccines (2025) Vol. 13, Iss. 4, pp. 403-403
Open Access
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines
Rian Van Rampelbergh, Sue Pavord, Luis Anaya-Velarde, et al.
Communications Medicine (2025) Vol. 5, Iss. 1
Open Access
Distinct platelet crosstalk with adaptive and innate immune cells after adenoviral and mRNA vaccination against SARS-CoV-2
Ludovica Lombardi, Francesca Maiorca, Ramona Marrapodi, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 6, pp. 1636-1649
Open Access | Times Cited: 9
Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
Sam Afkhami, Alisha Kang, Vidthiya Jeyanathan, et al.
Current Opinion in Virology (2023) Vol. 61, pp. 101334-101334
Open Access | Times Cited: 9
Autoimmune complications of COVID-19 and potential consequences for long-lasting disease syndromes
Jean Amiral, Jerard Seghatchian
Transfusion and Apheresis Science (2022) Vol. 62, Iss. 1, pp. 103625-103625
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top